These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18398226)

  • 41. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
    Vlacha V; Eliopoulou M; Haidas S; Beratis NG
    Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dextromethorphan Administration on Day 0 and Day 7 for Secondary Prevention of Methotrexate-induced Neurotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Case Series.
    Fustino NJ; Juhl K; Leister J
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e284-e287. PubMed ID: 31929386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis.
    Chan YL; Roebuck DJ; Yuen MP; Yeung KW; Lau KY; Li CK; Chik KW
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):759-63. PubMed ID: 11395245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parental report of everyday cognitive abilities among children treated for acute lymphoblastic leukemia.
    Williams KS; Ochs J; Williams JM; Mulhern RK
    J Pediatr Psychol; 1991 Feb; 16(1):13-26. PubMed ID: 2010875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Methotrexate toxicity during acute leukemia lymphoblastic].
    Lamchahab M; Benchekroun S
    Pan Afr Med J; 2014; 17():16. PubMed ID: 24932327
    [No Abstract]   [Full Text] [Related]  

  • 47. Brain white matter changes during treatment of a child for acute lymphoblastic leukemia.
    Maeda M; Hayakawa J; Ueda T; Migita M; Asano T; Fukunaga Y; Amano Y
    J Nippon Med Sch; 2005 Oct; 72(5):252-3. PubMed ID: 16247223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children.
    Seidel H; Nygaard R; Haave I; Moe PJ
    Acta Paediatr; 1996 Apr; 85(4):450-3. PubMed ID: 8740303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
    Manabe A; Tsuchida M; Hanada R; Ikuta K; Toyoda Y; Okimoto Y; Ishimoto K; Okawa H; Ohara A; Kaneko T; Koike K; Sato T; Sugita K; Bessho F; Hoshi Y; Maeda M; Kinoshita A; Saito T; Tsunematsu Y; Nakazawa S
    J Clin Oncol; 2001 Jul; 19(13):3182-7. PubMed ID: 11432884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.
    Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE
    J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case report on hypersensitivity to methotrexate infusion in a pediatric acute lymphoblastic leukaemia patient.
    Sajith M; Pawar A; Bafna V; Bartakke S
    J Oncol Pharm Pract; 2020 Mar; 26(2):462-464. PubMed ID: 30961436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Griffioen PH; den Hoed MAH; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
    PLoS One; 2018; 13(7):e0199574. PubMed ID: 29985926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas.
    Hiraga S; Arita N; Ohnishi T; Kohmura E; Yamamoto K; Oku Y; Taki T; Sato M; Aozasa K; Yoshimine T
    J Neurosurg; 1999 Aug; 91(2):221-30. PubMed ID: 10433310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment.
    Koh S; Nelson MD; Kovanlikaya A; Chen LS
    Pediatr Neurol; 1999 Aug; 21(2):576-8. PubMed ID: 10465148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.
    Krull KR; Hockenberry MJ; Miketova P; Carey M; Moore IM
    Leuk Lymphoma; 2013 Mar; 54(3):535-40. PubMed ID: 22856670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Methotrexate-induced interstitial pneumonitis in a child with acute lymphoblastic leukemia].
    Tatsumoto C; Kawakami K; Nagayama J; Kawano H
    Rinsho Ketsueki; 2004 Oct; 45(10):1100-4. PubMed ID: 15553044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia.
    Sauer M; Rydholm N; Piatkowski J; Lewis V; Steiner M
    Pediatr Hematol Oncol; 2002 Mar; 19(2):135-40. PubMed ID: 11881788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI.
    Halsey C; Buck G; Richards S; Vargha-Khadem F; Hill F; Gibson B
    J Hematol Oncol; 2011 Oct; 4():42. PubMed ID: 21996369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose methotrexate in childhood all.
    Moe PJ; Holen A
    Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.